Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 31882701000001116 | Mucopolysaccharide polysulphate + Salicylic acid (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 75212401000001112 | Salicylic acid + Mucopolysaccharide polysulfate | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mucopolysaccharide polysulphate + Salicylic acid | Is a | Product containing salicylate | true | Inferred relationship | Existential restriction modifier | ||
| Mucopolysaccharide polysulphate + Salicylic acid | Has active ingredient | Salicylate | false | Inferred relationship | Existential restriction modifier | ||
| Mucopolysaccharide polysulphate + Salicylic acid | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Mucopolysaccharide polysulphate + Salicylic acid | Has active ingredient | Salicylate | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream | Is a | True | Mucopolysaccharide polysulphate + Salicylic acid | Inferred relationship | Existential restriction modifier | |
| Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel | Is a | True | Mucopolysaccharide polysulphate + Salicylic acid | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR